2024 annual financial data

Rani Therapeutics Holdings 2024 Net margin

Direct answer

Net margin was -2,920.04%.

Operating income was -53,314,000 USD and net income was -30,018,000 USD.
Operating cash flow was -35,496,000 USD.

Get free Rani Therapeutics Holdings email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
1,028,000 USD
Operating income
-53,314,000 USD
Net income
-30,018,000 USD
Operating cash flow
-35,496,000 USD